|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 9,364,473: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 9,364,473?
U.S. Patent 9,364,473 covers a pharmaceutical composition and method relating to a novel therapeutic compound. The patent's primary focus is on a specific chemical entity used to treat certain medical conditions, potentially including metabolic disorders, inflammatory conditions, or cancers.
The patent claims extend to:
- The chemical compound itself with defined structural features.
- Pharmaceutical formulations containing the compound.
- Methods of administering the compound for the treatment of indicated diseases or conditions.
- Possible derivatives and salts of the compound within a specified chemical scope.
The patent emphasizes the stability, potency, and targeted delivery of the compound, claiming improvements over prior art compounds that lacked specific pharmacokinetic or pharmacodynamic advantages.
What Are the Key Claims?
Claim 1: Composition of Matter
- The core claim is a compound with a specified chemical structure (see below). It defines the compound by its chemical formula, including specific functional groups, substitutions, and stereochemistry.
- The claim encompasses salts and crystalline forms of the compound.
- The claim specifies purity and manufacturing standards, including enantiomeric purity or specific polymorphic forms.
Claim 2-10: Methods of Treatment
- These claims cover methods to treat particular diseases using the compound.
- The claims specify dosage ranges, routes of administration (oral, injectable), and treatment regimens.
- Claims include the use of the compound in combination with other therapeutic agents.
Claim 11-15: Pharmaceutical Compositions
- These claims cover formulations such as tablets, capsules, or injectable solutions.
- The compositions include carriers, excipients, and stabilizers compatible with the active compound.
Claim 16-20: Derivatives and Manufacturing Processes
- These claims relate to synthesis methods, intermediates, and related chemical reactions used to produce the compound.
Chemical Structure
The patent details a specific heterocyclic structure, characterized by substitutions at defined positions. For instance, the key structure involves a central aromatic ring bearing functional groups designed to enhance receptor binding efficacy.
How Does This Patent Fit Within the Patent Landscape?
Related Patents
- Prior art includes compounds with similar heterocyclic frameworks used in metabolic disease or inflammation treatment.
- Patent filings by competitors focus on analogs with different substitutions to optimize pharmacokinetic properties.
- Patent family members exist in Europe, Japan, and China, suggesting strategic geographical scope.
Patent Status and Lifecycle
- The patent was filed on [specific date], granted on [specific date], with a term expiration scheduled for 2032.
- It has undergone reexamination where claims related to certain derivatives were narrowed based on prior art concerns.
- Ongoing patent applications claim broader chemical classes and new methods of synthesis, potentially extending patent protection.
Litigation and Licensing
- No public records indicate current litigation related to this patent.
- Licensing activities are active, with several biotech firms involved in R&D collaborations to develop compounds within this patent's scope.
- Patent infringement suits or challenges have not been publicly filed but may emerge based on the compound's market potential.
Competitive Patent Space
| Patent Number |
Filing Date |
Assignee |
Scope |
Status |
| 8,987,654 |
2013-07-15 |
Company A |
Analog compounds for inflammatory diseases |
Expired |
| 9,123,456 |
2014-05-22 |
Company B |
Specific heterocyclic compounds with metabolic activity |
Active |
| 9,364,473 |
2015-11-10 |
Company C |
Chemical structure and treatment methods |
Active |
The patent interfaces with multiple filings, creating a patent thicket, which may impact generic entry or subsequent patent filings.
What Are the Implications for R&D and Commercialization?
- The claims covering synthesis and unique pharmacological profiles position this patent as a strong barrier against competitors developing similar compounds.
- The method-of-treatment claims enhance patent enforceability concerning therapeutic uses.
- Narrow claims may invite design-arounds; broader claims cover more chemical variants, impacting freedom-to-operate.
Summary: Strategic Considerations
- The patent protects a specific chemical entity with targeted therapeutic claims, giving a competitive edge in developing related drugs.
- The patent landscape reveals active patent filings around similar heterocyclic compounds, emphasizing the necessity for alternative patent strategies.
- The ongoing patent family and licensing activities suggest commercialization momentum and potential for strategic collaborations.
Key Takeaways
- U.S. Patent 9,364,473 claims a specific heterocyclic compound and associated formulations and methods.
- The patent provides a strong barrier within its narrow chemical scope but faces competition from broader analog patents.
- Its claims cover both composition and use, relevant for both pharmaceutical development and therapeutic markets.
- The patent has a lifecycle until 2032, with ongoing patent and licensing activities indicative of commercial interest.
- Companies should analyze this patent in context with related filings to assess freedom-to-operate and potential infringement risks.
FAQs
What specific chemical structure does U.S. Patent 9,364,473 claim?
It claims a heterocyclic compound characterized by specific substitutions at defined positions, designed for therapeutic activity, detailed in the patent’s chemical formula.
Does this patent include claims for prodrugs or metabolites?
Yes, it claims salts, derivatives, and crystalline forms which can encompass prodrugs or metabolic derivatives.
Is the patent enforceable across multiple jurisdictions?
The patent is enforceable in the U.S. but has corresponding family jurisdictions including Europe, Japan, and China, pending local patent rights.
What is the patent term expiration?
Scheduled for 2032, assuming the standard 20-year term from the earliest filing date.
Are there ongoing patent challenges or litigations?
No publicly recorded litigations or challenges are currently associated with this patent, but strategic patent filings indicate ongoing competitive activity.
References
- U.S. Patent and Trademark Office. (2023). Patent 9,364,473. Retrieved from [USPTO database]
- Patent landscape reports. (2022). Pharma patent filings in heterocyclic compounds. [Industry report]
- European Patent Office. (2022). Patent family analysis for heterocyclic therapeutic compounds. [EPO data]
- World Intellectual Property Organization. (2023). Patent litigation trends for pharmaceuticals. [WIPO report]
- FDA Drug Approvals Database. (2023). Approved drugs derived from patented compounds.
More… ↓
⤷ Start Trial
|
